TAKTakeda Pharmaceutical Company Limited
$18.73+24% 1Y
$18.73
$13.2352 weeks$19.05
Is the price fair?
What TAK's price assumes
Takeda Pharmaceutical Company Limited has no trailing P/E on file, so the price is measured against sales instead: 0.00× revenue.
0.00
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 0.00
Price / book · as of 2025-FY
- EV / sales
- 0.25
EV / sales
Details›
- Price / bookas of 2025-FY
- 0.00
- EV / EBITas of 2025-FY
- 2.75
- EV / salesas of 2025-FY
- 0.25
- Market capitalisation
- $49.5B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, Specialty & Generic
Ranks #15 of 41 by RyuScore